Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Merck recently broke ground on a factory in Delaware that is expected to begin making Keytruda in 2030.
Simplified Text
Merck broke ground on a factory in Delaware expected to begin making Keytruda in 2030.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "date": "2030",
    "topic": "Pharma Tariffs",
    "location": "Delaware",
    "source_type": "News Article",
    "organization": "Merck"
}
Subject Tags
UUID
9fdae14b-01c1-4969-a737-56b2b5628d1b
Vector Index
✗ No vector
Created
September 11, 2025 at 8:58 PM (3 days ago)
Last Updated
September 11, 2025 at 8:58 PM (3 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html

US drugmakers using Ireland for tax advantages face billions in tariffs on European medicines. Shifting production to the US increases costs. The situation highlights tax strategies and their impact.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP